Oncotarget
Author Insight: Cancer Drug Prices in Low- and Middle-Income Countries
Feb 15, 2022
Dr. Bishal Gyawali discusses the challenges of affordable cancer drugs in low and middle-income countries. Topics include prioritizing effective treatments, disparities in drug pricing, and the need for policy changes to ensure access to essential cancer care services.
07:58
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Affordability is crucial in cancer economics despite cheaper drug prices in certain countries.
- Prioritize highly effective cancer drugs over costly less effective medications for improved care in low and middle income countries.
Deep dives
Disparities in Cancer Drug Prices and Affordability
The podcast focuses on the disparities in cancer drug prices and affordability, highlighting a study that quantified the variations in drug costs globally. Despite cheaper drug prices in certain countries like India, the drugs remained unaffordable for many patients in low and middle income countries. This challenges the conventional discussion about the value of cancer drugs, emphasizing that affordability is a crucial aspect of cancer economics.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
